Experimental design | Group A (1 × 105 CFU) | Group B (1 × 104 CFU) |
|---|
| | No-IE | Faint IE | Severe IE | No-IE | Faint IE | Severe IE |
|---|
Numbers | 12 | 21 | 12 | 36 | 9 | 0 |
LV/RV ratio | 2.05 ± 0.23 | 2.06 ± 0.22 | 1.94 ± 0.22 | 2.06 ± 0.35 | 2.01 ± 0.18 | 1.96 ± 0.10 |
VTR (m/s) | 0.53 ± 0.26 | 0.59 ± 0.22 | 0.66 ± 0.24 | 0.53 ± 0.25 | 0.58 ± 0.21 | 0.62 ± 0.29 |
ΔPRA (mmHg) | 2.48 ± 1.00 | 7.81 ± 1.21*
| 13.11 ± 1.31#
| 2.98 ± 1.08 | 7.6 ± 1.32*
| 12.73 ± 1.44#
|
-
No-IE: Did not develop IE by echocardiography or by histologic findings; Faint IE: Infectious endocarditis could confirmed by histologic findings but not visualized by echocardiography; Severe IE: Infectious endocarditis confirmed by both echocardiography and histologic findings. LV: Left ventricle; RV: Right ventricle; V
TR
: Peak velocity of tricuspid valve regurgitation; ΔP
RA
: Right atrial pressure before and just after valvular impairment was used to calculate alterations of right atrial pressure, indicated as ΔPRA.
-
*
P < 0.01, Faint IE vs. None-IE; #
P < 0.01, Severe IE vs. Faint IE.
